DR. MICHAEL PATRICK O'ROURKE, MD
Medical Practice at 1 St, Jordan, MN

License number
Minnesota 44791
Category
Osteopathic Medicine
Type
Family Medicine
License number
Minnesota 44791
Category
Osteopathic Medicine
Type
Adolescent Medicine
License number
Minnesota 44791
Category
Osteopathic Medicine
Type
Geriatric Medicine
License number
Minnesota 44791
Category
Osteopathic Medicine
Type
Sports Medicine
License number
Minnesota 44791
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
1400 1St St NE, Jordan, MN 56071
Phone
(652) 758-2535
(952) 548-6160 (Fax)
(952) 758-2535

Professional information

Michael P O'Rourke Photo 1

Dr. Michael P O'rourke, Cloquet MN - MD (Doctor of Medicine)

Specialties:
Family Medicine
Address:
512 Skyline Blvd, Cloquet 55720
(218) 879-4641 (Phone)
Parkview Medical Clinic
1400 1St St NE, New Prague 56071
(952) 758-2535 (Phone)
612 S Sibley Ave, Litchfield 55355
(320) 693-3242 (Phone)
Certifications:
Family Practice, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Saint Louis University School Of Medicine
Graduated: 2000
St Louis University School Of Med
University Of Mn Med School


Michael Patrick O'Rourke Photo 2

Michael Patrick O'Rourke, New Prague MN

Specialties:
Family Medicine, Adolescent Medicine, Sports Medicine
Work:
Parkview Medical Clinic
1400 1St St NE, New Prague, MN 56071
Education:
Saint Louis University (2000)


Michael Patrick O'Rourke Photo 3

Michael Patrick O'Rourke, New Prague MN

Specialties:
Family Physician
Address:
1400 1St St Ne, New Prague, MN 56071
Education:
Doctor of Medicine


Michael O'Rourke Photo 4

Adherence Inhibitor Directed To And Method Of Making And Using

US Patent:
2008031, Dec 18, 2008
Filed:
Nov 1, 2007
Appl. No.:
11/933778
Inventors:
Peter Nash - Eden Prairie MN, US
Bradley M. Mitteness - Ghent MN, US
Michael O'Rourke - New Prague MN, US
Assignee:
Camas Incorporated - LeCenter MN
International Classification:
A61K 39/395, A61P 31/04
US Classification:
4241651
Abstract:
A method for the production of antibodies or microbial adherents administers is disclosed. The antibodies or microbial adherents inhibitors are administered to a patient suffering from strep throat to substantially prevent the adherents of colony-forming immunogens or haptens in the throat of the patient. Application of the antibodies should decrease the colonization of the oropharnyx, and therefore decrease symptoms of the sore inflamed throat and ultimately decrease the need for antibiotics.